Page last updated: 2024-12-06
inophyllum b
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
inophyllum B: inophyllum P is an active enantiomer of B; from Calophyllum inophyllum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Calophyllum | genus | A plant genus of the family CLUSIACEAE. Members contain costatolide, calanolides and 4-phenylfuranocoumarins (FUROCOUMARINS).[MeSH] | Calophyllaceae | [no description available] |
Cross-References
ID Source | ID |
---|---|
PubMed CID | 72412 |
CHEMBL ID | 337029 |
SCHEMBL ID | 2040583 |
MeSH ID | M0228262 |
Synonyms (11)
Synonym |
---|
bdbm50029982 |
NSC664738 |
41135-06-2 |
inophyllum b |
(2r,3r,4s)-4-hydroxy-2,3,10,10-tetramethyl-8-phenyl-2h-pyrano[6,5-f]2h-pyrano[6,5-h]chroman-6-one |
CHEMBL337029 , |
2h,6h,10h-benzo(1,2-b:3,4-b':5,6-b'')tripyran-2-one, 11,12-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-phenyl-, (10alpha,11beta,12alpha)-(+)- |
SCHEMBL2040583 |
DTXSID60194070 |
CS-0373940 |
HY-142074 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (1)
Inhibition Measurements
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | IC50 (µMol) | 0.2027 | 0.0001 | 1.0768 | 10.0000 | AID198252; AID198253; AID198254 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Activation Measurements
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | EC50 (µMol) | 0.2253 | 0.0004 | 0.6153 | 9.7000 | AID1407642 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Bioassays (8)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID198253 | Inhibitory concentration against HIV-1 reverse transcriptase mutant (Tyr-181 to Cys) | 1993 | Journal of medicinal chemistry, Dec-24, Volume: 36, Issue:26 | The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. |
AID1407642 | Inhibition of recombinant HIV-1 reverse transcriptase RNA-dependent DNA polymerase activity using poly(rA)/oligo(dT)16 as template/primer preincubated for 5 to 10 mins followed by template/primer addition and measured after 16 hrs by colorimetric assay | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. |
AID1407641 | Inhibition of recombinant HIV-1 reverse transcriptase RNA-dependent DNA polymerase activity at 1 ug/ml using poly(rA)/oligo(dT)16 as template/primer preincubated for 5 to 10 mins followed by template/primer addition and measured after 16 hrs by colorimetr | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. |
AID125356 | Tested for cytotoxicity in Molt-4 cells by XTT assay | 1993 | Journal of medicinal chemistry, Dec-24, Volume: 36, Issue:26 | The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. |
AID198254 | Inhibitory concentration against HIV-1 reverse transcriptase mutant (Tyr-181 to Leu) | 1993 | Journal of medicinal chemistry, Dec-24, Volume: 36, Issue:26 | The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. |
AID198252 | Inhibitory concentration against HIV-1 reverse transcriptase in scintillation proximity assay | 1993 | Journal of medicinal chemistry, Dec-24, Volume: 36, Issue:26 | The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. |
AID81589 | Anti-HIV activity against HIV-1 in Molt-4 cells using 7-day infective assay | 1993 | Journal of medicinal chemistry, Dec-24, Volume: 36, Issue:26 | The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. |
AID232755 | Selectivity index is the ratio of cytotoxicity in Molt-4 cells and anti-HIV- IC50 | 1993 | Journal of medicinal chemistry, Dec-24, Volume: 36, Issue:26 | The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.36) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |